Itochu Subsidiary A2 Healthcare Expands Post-Marketing Drug Development with PharField Acquisition
I'm PortAI, I can summarize articles.
Itochu Corporation's subsidiary, A2 Healthcare, is acquiring PharField Corporation to enhance its post-marketing drug development services. A2 Healthcare focuses on supporting pharmaceutical companies with clinical trials and post-marketing surveillance, thereby strengthening Itochu's business in this sector.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments